全身麻醉藥物市場機會、成長動力、產業趨勢分析與預測 2025 - 2034

General Anesthesia Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2025年01月13日 | 出版商:

Global Market Insights Inc. | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年全球全身麻醉藥物市場價值為 54 億美元，預計在 2025 年至 2034 年期間將以 3.6% 的複合年成長率穩步成長。隨著全球醫療保健系統的不斷進步，人口老化、醫療保健涵蓋範圍的擴大和微創技術的進步推動了手術量的增加，對有效麻醉藥物的需求也在上升。麻醉藥物配方的創新旨在提高患者安全性和最佳化恢復時間，進一步推動該市場的成長。

市場的主要參與者專注於廣泛的臨床研究和開發，以提高麻醉藥物的安全性和有效性，確保其能夠滿足日益成長的外科手術需求。以患者為中心的醫療保健解決方案的推動也推動了對具有快速起效、作用時間短、副作用小等特點的麻醉劑的投資，使其適合於門診和當日手術。這些發展預計將促進全球市場發展，鞏固其在支持外科手術和診斷進步方面的關鍵作用。

市場範圍
起始年份	2024
預測年份	2025-2034
起始值	54億美元
預測值	77億美元
複合年成長率	3.6％

市場涵蓋各種藥物，包括七氟醚、丙泊酚、右美托咪啶、瑞芬太尼、地氟醚、咪達唑侖、氯胺酮等。其中，丙泊酚在2024年成為領先藥物，佔27.5%的市佔率。丙泊酚因其起效快、作用時間短、恢復平穩而聞名，仍是全身麻醉的首選，尤其是在門診環境中。丙泊酚具有充分證據的安全性和有效性，加上廣泛的監管部門批准，已成為現代麻醉實踐的基石。

從應用角度來看，全身麻醉藥物市場分為神經外科、心血管外科、骨科和其他外科手術。 2024 年，骨科手術將引領市場，創造 20 億美元的收入。肌肉骨骼疾病盛行率的不斷上升以及關節鏡等微創手術技術的日益普及，增加了該領域對全身麻醉的需求。全身麻醉可確保最佳的肌肉放鬆和鎮靜，這對於此類手術的成功至關重要。隨著這些技術變得越來越容易取得，對麻醉藥物的需求將持續上升，從而推動整體市場的成長。

預計美國將主導市場，預計到 2034 年其估值將達到 32 億美元。選擇性和緊急性手術的穩定增加凸顯了對可靠有效的麻醉藥物的需求，確保了患者的安全並促進了該地區市場的持續成長。

The Global General Anesthesia Drugs Market, valued at USD 5.4 billion in 2024, is poised to grow at a steady CAGR of 3.6% from 2025 to 2034. General anesthesia drugs play an indispensable role in modern medicine, facilitating a controlled, reversible state of unconsciousness essential for a wide array of surgical procedures. As global healthcare systems continue to advance, the demand for effective anesthesia drugs is rising alongside increased surgical volumes, driven by aging populations, expanding healthcare access, and advancements in minimally invasive techniques. Innovations in anesthesia drug formulations, designed to enhance patient safety and optimize recovery times, further fuel this market's growth.

Key players in the market focus on extensive clinical research and development to improve the safety profiles and efficacy of anesthesia drugs, ensuring their readiness to meet the growing surgical demand. The push for patient-centric healthcare solutions also drives investments in anesthetics that offer rapid onset, short duration of action, and minimal side effects, making them suitable for outpatient and same-day procedures. These developments are expected to bolster the global market, cementing its critical role in supporting surgical and diagnostic advancements.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$5.4 Billion
Forecast Value	$7.7 Billion
CAGR	3.6%

The market encompasses various drugs, including sevoflurane, propofol, dexmedetomidine, remifentanil, desflurane, midazolam, ketamine, and others. Among these, propofol emerged as the leading drug in 2024, capturing 27.5% of the market share. Renowned for its rapid onset, short duration of action, and smooth recovery profile, propofol remains a preferred choice for general anesthesia, particularly in outpatient settings. Its well-documented safety and efficacy, coupled with widespread regulatory approvals, have established propofol as a cornerstone in modern anesthetic practices.

From an application perspective, the general anesthesia drugs market is segmented into neurological, cardiovascular, orthopedic, and other surgeries. Orthopedic surgeries led the market in 2024, generating USD 2 billion in revenue. The rising prevalence of musculoskeletal disorders and the increasing adoption of minimally invasive surgical techniques, such as arthroscopy, have heightened the demand for general anesthesia in this segment. General anesthesia ensures optimal muscle relaxation and sedation, which are critical for the success of such procedures. As these techniques become more accessible, the demand for anesthesia drugs will continue to rise, driving overall market growth.

The United States is expected to dominate the market, with projections indicating a valuation of USD 3.2 billion by 2034. This expansion is fueled by the growing number of complex and routine surgeries across specialties like cardiovascular, neurological, and orthopedic disciplines. The steady increase in both elective and emergency surgical procedures underscores the need for reliable and effective anesthesia drugs, ensuring patient safety and contributing to the sustained growth of the market in this region.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° Synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing volume of surgical procedures
  - 3.2.1.2 Advancements in anesthesia technology
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Adverse effects and safety concerns
  - 3.2.2.2 Regulatory and compliance challenges
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Future market trends
3.7 Gap analysis
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

5.1 Key trends
5.2 Sevoflurane
5.3 Propofol
5.4 Dexmedetomidine
5.5 Remifentanil
5.6 Desflurane
5.7 Midazolam
5.8 Ketamine
5.9 Other drugs

Chapter 6 Market Estimates and Forecast, By Route of Administration, 2021 – 2034 ($ Mn)

6.1 Key trends
6.2 Intravenous
6.3 Inhalational

Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

7.1 Key trends
7.2 Neurological surgery
7.3 Cardiovascular surgery
7.4 Orthopedic surgery
7.5 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Ambulatory surgical centers
8.4 Specialty clinics

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE